|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Dissemination and evaluation of the ASAS/EULAR eeommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists 显示文摘 | GOSSEC L DOUGADOS M PHILLIPS C | 2008 | Ann Rheum Dis2008，67，6： | 1 |
| 2 | Efficacy and safety of adallmumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) 显示文摘 | SIEPER J VAN DER HEIJDE D DOUGADOS M | 2012 | Ann Rheum Dis2012，，： | 1 |
| 3 | Treatment of rheumatoid arthritis with the selective eostimulation modulator abatacept: twelve-month results of a phase Ⅱ b, double-blind, randomized, placebo-controlled trial显示文摘 | KREMER JM DOUGADOS M EMERY P | 2005 | Arthritis Rheum2005，52，8： | 1 |
| 4 | Ankylosing spondytitis: what is the optimtma duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial显示文摘 | Dougados M Gueguen A Nakache JP | 1999 | Rheumatology(Oxford)1999，38，3： | 1 |
| 5 | Treating rheumatoid arthritis to target: recommendations of an international task force 显示文摘 | Smolen JS Braun J Dougados M | 2010 | Ann Rheum Dis2010，69，4： | 1 |
| 6 | Treatment of rheumatoid arthritis with the selective costimulation mod-ulator abatacept:twelve-month results of a phase i b, double-blind, randomized, placebo-control ed trial显示文摘 | Kremer JM Dougados M Emery P | | 0，，06： | 1 |
| 7 | Fhysmal iunc- tion in ankylosing spondylitisis independently determined by both disease activity and radiographitc damage of the spine 显示文摘 | Landewe R Dougados M Mielants H | 2009 | Ann Rheum Dis2009，68，6： | 1 |
| 8 | Leflunomide in clinical practice显示文摘 | Pinto P Dougados M | 2006 | Acta Reumatol Port2006，31，： | 1 |
| 9 | The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy显示文摘 | Dougados M van der Linden S Juhlin R | 1991 | Arthritis Rheum1991，34，10： | 1 |
| 10 | Development of classification and response criteria for rheumatic diseases显示文摘 | Singh JA Solomon DH Dougados M | 2006 | Arthritis Rhenm2006，55，3： | 1 |
| 11 | The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy显示文摘 | Dougados M van der Linden S Juhlin R | 1991 | Arthritis Rheum1991，34，10： | 1 |
| 12 | EULAR recom- mendations for the management of knee osteoarthritis:re- port of a task force of the Standing Committee for Inter- national Clinical Studies Including Therapeutic Trials (ESCISIT) 显示文摘 | Pendleton A Arden N Dougados M | 2000 | Ann Rheum Dis2000，59，12： | 1 |
| 13 | Criteria for classification of spondyloarthropathies 显示文摘 | AMOR B DOUGADOS M MIJIAWA M | 1990 | Rev Rheum Mal Osteoartic1990，57，2： | 1 |
| 14 | The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy 显示文摘 | Dougados M van der Linden S Juhlin R | 1991 | Arthritis Rheum1991，34，10： | 1 |
| 15 | Leflunomide for the treatment of rheumatoid arthritis显示文摘 | Miceli-Richard C Dougados M | 2003 | Expert Opinion on Pharmacotherapy2003，4，6： | 1 |
| 16 | 难治性类风湿关节炎的临床特点:一项国际问卷调查研究显示文摘目的尽管按照目前欧洲抗风湿联盟(EULAR)的推荐对类风湿关节炎(rheumatoid arthritis,RA)患者进行治疗,难治性RA患者的临床症状却仍然没有得到完全控制,目前EULAR指南主要关注的是RA的早期治疗和药物治疗。本研究的目的在于分析难治性RA患者的临床特点,以及在患者管理中需要探索然而现有EULAR指南并未涉及的问题。方法对多个国家的风湿科医生进行问卷调查,分析难治性RA的临床特点。问卷包括多选题以及开放性问题,从开放性问题的回答中发现需要进一步阐明的问题以及现有EULAR指南需要增加的内容。结果410名受访者完成了调查问卷,关于难治性RA的特点:50%受访者认为基于28个关节评估的疾病活动评分(disease activity score assessing 28 joints,DAS28)>3.2或存在疾病活动的征象;42%受访者认为疲劳是其特点;48%认为至少两种传统合成改变病情抗风湿药(DMARDs)以及使用至少两种生物制剂或靶向合成DMARDs治疗失败;89%认为糖皮质激素不能减量到5 mg/天或泼尼松不能减量到10 mg/天或同等剂量的其他激素。另外,现有EULAR指南中应增加合并症和关节外表现的干预以及多种药物联合治疗等重要内容。结论目前风湿科医生对难治性RA的定义有很大争议。难治性RA患者的很多重要问题目前EULAR指南中均没有涉及。 | Nadia MT Roodenrijs Maria J H de Hair Marlies C van der Goes Johannes WG Jacobs Paco MJ Welsing Désirée van der Heijde Daniel Aletaha Maxime Dougados Kimme L Hyrich Iain B McInnes Ulf Mueller-Ladner Ladislav Senolt Zoltan Szekanecz Jacob Mvan Laar Nagy Gyorgy 黄艳荣(译) 张卓莉(审校) | 2019 | 英国医学杂志中文版2019，22，2： | 1 |
| 17 | The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy 显示文摘 | DOUGADOS M VAN DER LINDEN S JUHLIN R | 1991 | Arthritis Rheum1991，34，10： | 1 |
| 18 | Baseline factors that influence ASAS20response in patients with ankylosing spon-dylitis treated with a recombinant human tumor necosis factor-Fc fusion protein显示文摘 | Davis JC Van der Heijde DM Dougados M | 2005 | J Rheumatol2005，32，： | 1 |
| 19 | Comparison of sulfasalazine and placebo in the treatment of anky losing 显示文摘 | Dougados M yam der Linden S Leirisalo- Repo M | 1995 | Arthritis Rheum1995，38，5： | 1 |
| 20 | Spondyloarthritis显示文摘 | Dougados M Baeten D | 2011 | Lancet2011，377，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员